Elsayed A - Search Results

1

Stabilization of insulin using low molecular weight chitosan carbonate nanocarrier.

Al-Remawi M, Jaber N, Elsayed A, Alsafadi D, Salah KA. Al-Remawi M, et al. Among authors: elsayed a. Carbohydr Polym. 2022 Sep 1;291:119579. doi: 10.1016/j.carbpol.2022.119579. Epub 2022 May 11. Carbohydr Polym. 2022. PMID: 35698397

2

Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin.

Elsayed A, Al-Remawi M, Qinna N, Farouk A, Al-Sou'od KA, Badwan AA. Elsayed A, et al. AAPS PharmSciTech. 2011 Sep;12(3):958-64. doi: 10.1208/s12249-011-9647-5. Epub 2011 Jul 15. AAPS PharmSciTech. 2011. PMID: 21761276 Free PMC article.

3

Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system.

Elsayed A, Al-Remawi M, Maghrabi I, Hamaidi M, Jaber N. Elsayed A, et al. Int J Pharm. 2014 Jan 30;461(1-2):448-58. doi: 10.1016/j.ijpharm.2013.12.014. Epub 2013 Dec 22. Int J Pharm. 2014. PMID: 24368103

4

Oral delivery of insulin using a lipoamino acid nanocarrier system.

Al-Remawi M, Maghrabi I, Elsayed A, Hamaidi M, Jaber N. Al-Remawi M, et al. Among authors: elsayed a. Pharmazie. 2014 Sep;69(9):669-75. Pharmazie. 2014. PMID: 25272937

5

Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system.

Al-Remawi M, Elsayed A, Maghrabi I, Hamaidi M, Jaber N. Al-Remawi M, et al. Among authors: elsayed a. Pharm Dev Technol. 2017 May;22(3):390-398. doi: 10.1080/10837450.2016.1213745. Epub 2016 Jul 28. Pharm Dev Technol. 2017. PMID: 27470482

6

Low Molecular Weight Chitosan-Insulin Complexes Solubilized in a Mixture of Self-Assembled Labrosol and Plurol Oleaque and Their Glucose Reduction Activity in Rats.

Elsayed AM, Khaled AH, Al Remawi MM, Qinna NA, Abu Farsakh H, Badwan AA. Elsayed AM, et al. Mar Drugs. 2018 Jan 16;16(1):32. doi: 10.3390/md16010032. Mar Drugs. 2018. PMID: 29337857 Free PMC article.

7

Advances in buccal and oral delivery of insulin.

Elsayed A, Al-Remawi M, Jaber N, Abu-Salah KM. Elsayed A, et al. Int J Pharm. 2023 Feb 25;633:122623. doi: 10.1016/j.ijpharm.2023.122623. Epub 2023 Jan 19. Int J Pharm. 2023. PMID: 36681204 Review.

8

From cell factories to patients: Stability challenges in biopharmaceuticals manufacturing and administration with mitigation strategies.

Elsayed A, Jaber N, Al-Remawi M, Abu-Salah K. Elsayed A, et al. Int J Pharm. 2023 Oct 15;645:123360. doi: 10.1016/j.ijpharm.2023.123360. Epub 2023 Aug 30. Int J Pharm. 2023. PMID: 37657507 Review.

9

Formulation and characterization of an oily-based system for oral delivery of insulin.

Elsayed A, Remawi MA, Qinna N, Farouk A, Badwan A. Elsayed A, et al. Eur J Pharm Biopharm. 2009 Oct;73(2):269-79. doi: 10.1016/j.ejpb.2009.06.004. Epub 2009 Jun 7. Eur J Pharm Biopharm. 2009. PMID: 19508890

10

Enhancement of oral bioavailability of insulin in humans.

Badwan A, Remawi M, Qinna N, Elsayed A, Arafat T, Melhim M, Hijleh OA, Idkaidek NM. Badwan A, et al. Among authors: elsayed a. Neuro Endocrinol Lett. 2009 Mar;30(1):74-8. Neuro Endocrinol Lett. 2009. PMID: 19300394 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,297 results

Search Page

Filters